{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T15:22:14Z","timestamp":1780500134334,"version":"3.54.1"},"reference-count":28,"publisher":"International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DD&amp;T"],"published-print":{"date-parts":[[2024,6,30]]},"DOI":"10.5582\/ddt.2024.01026","type":"journal-article","created":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T22:09:59Z","timestamp":1719353399000},"page":"194-198","source":"Crossref","is-referenced-by-count":1,"title":["Induction of acute silkworm hemolymph melanization by &lt;i&gt;Staphylococcus aureus&lt;\/i&gt; treated with peptidoglycan-degrading enzymes"],"prefix":"10.5582","volume":"18","author":[{"given":"Yasuhiko","family":"Matsumoto","sequence":"first","affiliation":[{"name":"Department of Microbiology, Meiji Pharmaceutical University, Tokyo, 204-8588, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eri","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Meiji Pharmaceutical University, Tokyo, 204-8588, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Sugita","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Meiji Pharmaceutical University, Tokyo, 204-8588, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3542","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Leung DYM. Atopic dermatitis: New insights and opportunities for therapeutic intervention. J Allergy Clin Immunol. 2000; 105:860-876.","DOI":"10.1067\/mai.2000.106484"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Smythe P, Wilkinson HN. The skin microbiome: Current landscape and future opportunities. Int J Mol Sci. 2023; 24:3950.","DOI":"10.3390\/ijms24043950"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Kong HH, Oh J, Deming C, Conlan S, Grice EA, Beatson MA, Nomicos E, Polley EC, Komarow HD, NISC Comparative Sequence Program; Murray PR, Turner ML, Segre JA. Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis. Genome Res. 2012; 22:850-859.","DOI":"10.1101\/gr.131029.111"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Luger T, Amagai M, Dreno B, Dagnelie M-A, Liao W, Kabashima K, Schikowski T, Proksch E, Elias PM, Simon M, Simpson E, Grinich E, Schmuth M. Atopic dermatitis: Role of the skin barrier, environment, microbiome, and therapeutic agents. J Dermatol Sci. 2021; 102:142-157.","DOI":"10.1016\/j.jdermsci.2021.04.007"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Tamagawa-Mineoka R. Toll-like receptors: their roles in pathomechanisms of atopic dermatitis. Front Immunol. 2023; 14:1239244.","DOI":"10.3389\/fimmu.2023.1239244"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Hankiewicz J, Swierczek E. Lysozyme in human body fluids. Clin Chim Acta. 1974; 57:205-209.","DOI":"10.1016\/0009-8981(74)90398-2"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Papini M, Simonetti S, Franceschini S, Scaringi L, Binazzi M. Lysozyme distribution in healthy human skin. Arch Dermatol Res. 1981; 272:167-170.","DOI":"10.1007\/BF00510410"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Boksha IS, Lavrova NV, Grishin AV, Demidenko AV, Lyashchuk AM, Galushkina ZM, Ovchinnikov RS, Umyarov AM, Avetisian LR, Chernukha Mlu, Shaginian IA, Lunin VG, Karyagina AS. <i>Staphylococcus simulans<\/i> recombinant lysostaphin: Production, purification, and determination of antistaphylococcal activity. Biochem (Mosc). 2016; 81:502-510.","DOI":"10.1134\/S0006297916050072"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Shields BE, Tschetter AJ, Wanat KA. <i>Staphylococcus simulans<\/i>: An emerging cutaneous pathogen. JAAD Case Rep. 2016; 2:428-429.","DOI":"10.1016\/j.jdcr.2016.08.015"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Far BE, Ragheb M, Rahbar R, Mafakher L, Nojookambari NY, Achinas S, Yazdansetad S. Cloning and expression of <i>Staphylococcus simulans<\/i> lysostaphin enzyme gene in <i>Bacillus subtilis<\/i> WB600. AIMS Microbiol. 2021; 7:271-283.","DOI":"10.21203\/rs.3.rs-122682\/v1"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Chipman DM, Schimmel PR. Dynamics of lysozymesaccharide interactions. J Biol Chem. 1968; 243:3771-3774.","DOI":"10.1016\/S0021-9258(18)97830-0"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Matsui M, Kono H, Ogata M. Molecular design and synthesis of a novel substrate for assaying lysozyme activity. J Appl Glycosci. 2018; 65:31-36.","DOI":"10.5458\/jag.jag.JAG-2018_003"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Gonzalez-Delgado LS, Walters-Morgan H, Salamaga B, Robertson AJ, Hounslow AM, Jagielska E, Saba\u0142a I, Williamson MP, Lovering AL, Mesnage S. Two-site recognition of <i>Staphylococcus aureus<\/i> peptidoglycan by lysostaphin SH3b. Nat Chem Biol. 2020; 16:24-30.","DOI":"10.1038\/s41589-019-0393-4"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Ishii K, Hamamoto H, Sekimizu K. Studies of host-pathogen interactions and immune-related drug development using the silkworm: interdisciplinary immunology, microbiology, and pharmacology studies. Drug Discov Ther. 2015; 9:238-246.","DOI":"10.5582\/ddt.2015.01015"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Matsumoto Y, Sekimizu K. Silkworm as an experimental animal for research on fungal infections. Microbiol Immunol. 2019; 63:41-50.","DOI":"10.1111\/1348-0421.12668"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Matsumoto Y. Facilitating drug discovery in human disease models using insects. Biol Pharm Bull. 2020; 43:216-220.","DOI":"10.1248\/bpb.b19-00834"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Lemaitre B, Hoffmann J. The host defense of <i>Drosophila melanogaster<\/i>. Annu Rev Immunol. 2007; 25:697-743.","DOI":"10.1146\/annurev.immunol.25.022106.141615"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Lu A, Zhang Q, Zhang J, Yang B, Wu K, Xie W, Luan YX, Ling E. Insect prophenoloxidase: The view beyond immunity. Front Physiol. 2014; 5:252.","DOI":"10.3389\/fphys.2014.00252"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Lindsay SA, Wasserman SA. Conventional and non-conventional <i>Drosophila<\/i> Toll signaling. Dev Comp Immunol. 2014; 42:16-24.","DOI":"10.1016\/j.dci.2013.04.011"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Miyashita A, Hamamoto H, Sekimizu K. Applying the silkworm model for the search of immunosuppressants. Drug Discov Ther. 2021; 15:139-142.","DOI":"10.5582\/ddt.2021.01041"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Li W, Miyashita A, Sekimizu K. Peanut triacylglycerols activate innate immunity both in insects and mammals. Sci Rep. 2022; 12:7464-7469.","DOI":"10.1038\/s41598-022-11494-0"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Ishii K, Hamamoto H, Imamura K, Adachi T, Shoji M, Nakayama K, Sekimizu K. <i>Porphyromonas gingivalis<\/i> peptidoglycans induce excessive activation of the innate immune system in silkworm larvae. J Biol Chem. 2010; 285:33338-33347.","DOI":"10.1074\/jbc.M110.112987"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Yasu T, Matsumoto Y, Sugita T. Pharmacokinetics of voriconazole and its alteration by <i>Candida albicans<\/i> infection in silkworms. J Antibiot. 2021; 74:443-449.","DOI":"10.1038\/s41429-021-00428-z"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Matsumoto Y, Sato E, Sugita T. Acute melanization of silkworm hemolymph by peptidoglycans of the human commensal bacterium <i>Cutibacterium acnes<\/i>. PLoS ONE. 2022; 17:e0271420.","DOI":"10.1371\/journal.pone.0271420"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Kaito C, Akimitsu N, Watanabe H, Sekimizu K. Silkworm larvae as an animal model of bacterial infection pathogenic to humans. Microb Pathog. 2002; 32:183-190.","DOI":"10.1006\/mpat.2002.0494"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Chen K, Lu Z. Immune responses to bacterial and fungal infections in the silkworm, <i>Bombyx mori<\/i>. Dev Comp Immunol. 2018; 83:3-11.","DOI":"10.1016\/j.dci.2017.12.024"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Zhang K, Tan J, Su J, Liang H, Shen L, Li C, <i>et al<\/i>. Integrin \u03b23 plays a novel role in innate immunity in silkworm, <i>Bombyx mori<\/i>. Dev Comp Immunol. 2017; 77:307-317.","DOI":"10.1016\/j.dci.2017.08.009"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Sugai M, Fujiwara T, Akiyama T, Ohara M, Komatsuzawa H, Inoue S, Suginaka H. Purification and molecular characterization of glycylglycine endopeptidase produced by <i>Staphylococcus capitis<\/i> EPK1. J Bacteriol. 1997; 179:1193-1202.","DOI":"10.1128\/jb.179.4.1193-1202.1997"}],"container-title":["Drug Discoveries &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ddt\/18\/3\/18_2024.01026\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,13]],"date-time":"2024-07-13T04:29:57Z","timestamp":1720844997000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ddt\/18\/3\/18_2024.01026\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,30]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.5582\/ddt.2024.01026","relation":{},"ISSN":["1881-7831","1881-784X"],"issn-type":[{"value":"1881-7831","type":"print"},{"value":"1881-784X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,30]]},"article-number":"2024.01026"}}